Lapenoria, Vergie S.
HRN: 25-23-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2025
METRONIDAZOLE 500MG (TAB)
01/02/2025
01/08/2025
PO
500
TID
Thickly Msaf
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes